Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06459687
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-06-03
Brief Title:
Phase III Study of Socazolimab as First-Line Treatment in Persistent Recurrent or Metastatic Cervical Cancer
Sponsor:
Lees Pharmaceutical Limited
Organization:
Lees Pharmaceutical Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-03
First Submit QC Date:
June 10 2024
Study First Post Date:
2024-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-10
Last Update Post Date:
2024-06-14
Last Update Post Date Type:
ACTUAL